Literature DB >> 22143968

Early fetal echocardiography: ready for prime time?

Fadi G Mirza1, Samuel T Bauer, Ismee A Williams, Lynn L Simpson.   

Abstract

The objective of this study was to examine the performance of early fetal echocardiography as a screening tool for major cardiac defects in a high-risk population. Fetal echocardiograms performed at 12 to 16 weeks were reviewed. Cases that did not undergo a follow-up echocardiogram at 18 to 22 weeks were excluded. Results of the early and follow-up echocardiograms were compared. Over a 4-year period, 119 early fetal echocardiograms were recorded. Of those, 81 (68%) had follow-up fetal echocardiograms. Results of the early echocardiogram were normal in 77 of 81 (95.1%) cases. Of these, the follow-up was normal in 75 of these 77 cases; in the remaining 2, the follow-up raised suspicion for a ventricular septal defect (VSD) in one and persistent left superior vena cava in the other. On the other hand, the early echocardiogram was abnormal in 4 (4.9%) cases: (1) atrioventricular canal defect, with the follow-up demonstrating a VSD; (2) hypoplastic right ventricle and transposition of the great arteries, confirmed on follow-up; (3) VSD and coarctation of the aorta, confirmed on follow-up. In the fourth case, the early echocardiogram suspected a VSD and right-left disproportion, yet the follow-up was normal. In conclusion, early fetal echocardiography appears to be a reasonable screening tool for major cardiac defects. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2011        PMID: 22143968      PMCID: PMC3681520          DOI: 10.1055/s-0031-1295640

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   1.862


  38 in total

1.  Early fetal echocardiography--a reliable prenatal diagnosis tool.

Authors:  Fionnuala M McAuliffe; Jean Trines; Lynne E Nield; David Chitayat; Edgar Jaeggi; Lisa K Hornberger
Journal:  Am J Obstet Gynecol       Date:  2005-09       Impact factor: 8.661

2.  Assessment of fetal anatomy at the 11-14-week ultrasound examination.

Authors:  A P Souka; A Pilalis; Y Kavalakis; Y Kosmas; P Antsaklis; A Antsaklis
Journal:  Ultrasound Obstet Gynecol       Date:  2004-12       Impact factor: 7.299

Review 3.  A systematic review of the accuracy of first-trimester ultrasound examination for detecting major congenital heart disease.

Authors:  S V Rasiah; M Publicover; A K Ewer; K S Khan; M D Kilby; J Zamora
Journal:  Ultrasound Obstet Gynecol       Date:  2006-07       Impact factor: 7.299

4.  Early diagnosis of major cardiac defects in chromosomally normal fetuses with increased nuchal translucency.

Authors:  N Zosmer; V L Souter; C S Chan; I C Huggon; K H Nicolaides
Journal:  Br J Obstet Gynaecol       Date:  1999-08

5.  ACC/AHA Guidelines for the Clinical Application of Echocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Application of Echocardiography). Developed in collaboration with the American Society of Echocardiography.

Authors:  M D Cheitlin; J S Alpert; W F Armstrong; G P Aurigemma; G A Beller; F Z Bierman; T W Davidson; J L Davis; P S Douglas; L D Gillam
Journal:  Circulation       Date:  1997-03-18       Impact factor: 29.690

6.  Nuchal translucency measurement and pregnancy outcome in karyotypically normal fetuses.

Authors:  G D Michailidis; D L Economides
Journal:  Ultrasound Obstet Gynecol       Date:  2001-02       Impact factor: 7.299

7.  Increased nuchal translucency at 10-14 weeks of gestation as a marker for major cardiac defects.

Authors:  J A Hyett; M Perdu; G K Sharland; R S Snijders; K H Nicolaides
Journal:  Ultrasound Obstet Gynecol       Date:  1997-10       Impact factor: 7.299

8.  First-trimester septated cystic hygroma: prevalence, natural history, and pediatric outcome.

Authors:  Fergal D Malone; Robert H Ball; David A Nyberg; Christine H Comstock; George R Saade; Richard L Berkowitz; Susan J Gross; Lorraine Dugoff; Sabrina D Craigo; Ilan E Timor-Tritsch; Stephen R Carr; Honor M Wolfe; Kimberly Dukes; Jacob A Canick; Diana W Bianchi; Mary E D'Alton
Journal:  Obstet Gynecol       Date:  2005-08       Impact factor: 7.661

9.  Nuchal translucency and the risk of congenital heart disease.

Authors:  Lynn L Simpson; Fergal D Malone; Diana W Bianchi; Robert H Ball; David A Nyberg; Christine H Comstock; George Saade; Keith Eddleman; Susan J Gross; Lorraine Dugoff; Sabrina D Craigo; Ilan E Timor-Tritsch; Stephen R Carr; Honor M Wolfe; Tara Tripp; Mary E D'Alton
Journal:  Obstet Gynecol       Date:  2007-02       Impact factor: 7.661

10.  Prenatal detection of congenital heart disease: factors affecting obstetric management and survival.

Authors:  D C Crawford; S K Chita; L D Allan
Journal:  Am J Obstet Gynecol       Date:  1988-08       Impact factor: 8.661

View more
  2 in total

Review 1.  Connecting teratogen-induced congenital heart defects to neural crest cells and their effect on cardiac function.

Authors:  Ganga H Karunamuni; Pei Ma; Shi Gu; Andrew M Rollins; Michael W Jenkins; Michiko Watanabe
Journal:  Birth Defects Res C Embryo Today       Date:  2014-09-15

2.  Determining the factors causing delayed referral for fetal echocardiography at a tertiary care hospital.

Authors:  Asma Kanwal; Abdul Malik Sheikh; Tayyaba Saher
Journal:  J Saudi Heart Assoc       Date:  2017-12-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.